In addition, Survivin has consistently been demonstrated to be overexpressed in solid human tumors and significantly correlates with tumor onset, more aggressive and advanced pathologic features, metastasis and worse prognosis as well as impaired patient’s survival [25,100,101]. The gene discussed is BIRC5; the disease is neoplasm.